Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT06447987 · SUSPENDED
Trial details
- NCT number
- NCT06447987
- Sponsor
- City of Hope Medical Center
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-06
- Primary completion
- 2026-12-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.